Please assess the completion status of the following clinical trial:

Trial Title: Safety, Tolerability and Host Response to Lactobacillus Johnsonii

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* To participate in the study individuals must~  * be 18-50 years old.~ * be willing to complete multiple questionnaires via computer.~ * be willing to take the probiotic or placebo capsule daily for 8 weeks.~ * be willing to provide 1 stool during weeks 0, 2, 4, 8 and 12 of the study.~ * be willing to provide blood samples at weeks -1, 0, 2, 4, 8 and 12 of the study.~ * have daily access to a computer with internet access for the entire 13-wk study.~ * be willing to provide a social security number~Exclusion Criteria:~* To participate in the study individuals must NOT~  * currently take medications for constipation, diarrhea or psychological disorders (depression, anxiety, insomnia etc.).~ * have taken antibiotics within the past four weeks prior to randomization.~ * currently take probiotic supplements and do not want to discontinue a minimum of two weeks prior to the study~ * have had or are currently being treated for any diseases or illnesses such as gastrointestinal disease (gastric ulcers, Crohn's, ulcerative colitis, etc.), chronic disease like diabetes or kidney disease, immune-compromising diseases or conditions (HIV, AIDS, hepatitis, cancer, transplant patient etc.)~ * currently receive medical treatment for stress induced symptoms/disorders~ * be a current smoker

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Probiotic (Type: ACTIVE_COMPARATOR): L. johnsonii N6.2 10\^10 CFU in capsule form administered for 8 weeks
- Placebo (Type: PLACEBO_COMPARATOR): Encapsulated starch placebo administered for 8 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).